These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9469504)

  • 21. Antidepressant use in the elderly. Current status of nefazodone, venlafaxine and moclobemide.
    Goldberg RJ
    Drugs Aging; 1997 Aug; 11(2):119-31. PubMed ID: 9259175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A preliminary open study of the tolerability and effectiveness of nefazodone in major depressive disorder: comparing patients who recently discontinued an SSRI with those on no recent antidepressant treatment.
    Mischoulon D; Opitz G; Kelly K; Fava M; Rosenbaum JF
    Depress Anxiety; 2004; 19(1):43-50. PubMed ID: 14978785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nefazodone and cyp450 3a4 interactions with cyclosporine and tacrolimus1.
    Garton T
    Transplantation; 2002 Sep; 74(5):745. PubMed ID: 12352898
    [No Abstract]   [Full Text] [Related]  

  • 24. Overview of the pharmacokinetics of fluvoxamine.
    van Harten J
    Clin Pharmacokinet; 1995; 29 Suppl 1():1-9. PubMed ID: 8846617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotonin syndrome associated with nefazodone and paroxetine.
    John L; Perreault MM; Tao T; Blew PG
    Ann Emerg Med; 1997 Feb; 29(2):287-9. PubMed ID: 9018197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Serious drug interaction between clozapine-Leponex and fluvoxamine-Fevarin].
    Olesen OV; Starup G; Linnet K
    Ugeskr Laeger; 1996 Nov; 158(48):6931-2. PubMed ID: 8984760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacology of antidepressants: focus on nefazodone.
    DeVane CL; Grothe DR; Smith SL
    J Clin Psychiatry; 2002; 63 Suppl 1():10-7. PubMed ID: 11890560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction between tacrolimus and nefazodone in a stable renal transplant recipient.
    Olyaei AJ; deMattos AM; Norman DJ; Bennett WM
    Pharmacotherapy; 1998; 18(6):1356-9. PubMed ID: 9855339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The safety profile of nefazodone.
    Robinson DS; Roberts DL; Smith JM; Stringfellow JC; Kaplita SB; Seminara JA; Marcus RN
    J Clin Psychiatry; 1996; 57 Suppl 2():31-8. PubMed ID: 8626361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nefazodone-induced carbamazepine toxicity.
    Ashton AK; Wolin RE
    Am J Psychiatry; 1996 May; 153(5):733. PubMed ID: 8615427
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluating the tolerability of the newer antidepressants.
    Dewan MJ; Anand VS
    J Nerv Ment Dis; 1999 Feb; 187(2):96-101. PubMed ID: 10067949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidepressant-induced sexual dysfunction.
    Segraves RT
    J Clin Psychiatry; 1998; 59 Suppl 4():48-54. PubMed ID: 9554321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antidepressant drug interactions and the cytochrome P450 system. The role of cytochrome P450 2D6.
    Ereshefsky L; Riesenman C; Lam YW
    Clin Pharmacokinet; 1995; 29 Suppl 1():10-8; discussion 18-9. PubMed ID: 8846618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluvoxamine: safety profile in extensive post-marketing surveillance.
    Buchberger R; Wagner W
    Pharmacopsychiatry; 2002 May; 35(3):101-8. PubMed ID: 12107854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism.
    Preskorn SH
    Clin Pharmacokinet; 1997; 32 Suppl 1():1-21. PubMed ID: 9068931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenacetin O-deethylation by human liver microsomes in vitro: inhibition by chemical probes, SSRI antidepressants, nefazodone and venlafaxine.
    von Moltke LL; Greenblatt DJ; Duan SX; Schmider J; Kudchadker L; Fogelman SM; Harmatz JS; Shader RI
    Psychopharmacology (Berl); 1996 Dec; 128(4):398-407. PubMed ID: 8986010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinically relevant drug interactions with new generation antidepressants and antipsychotics].
    Eckert A
    Ther Umsch; 2009 Jun; 66(6):485-92. PubMed ID: 19496045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluvoxamine. A review of global drug-drug interaction data.
    Wagner W; Vause EW
    Clin Pharmacokinet; 1995; 29 Suppl 1():26-31; discussion 31-2. PubMed ID: 8846620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human cytochromes and some newer antidepressants: kinetics, metabolism, and drug interactions.
    Greenblatt DJ; von Moltke LL; Harmatz JS; Shader RI
    J Clin Psychopharmacol; 1999 Oct; 19(5 Suppl 1):23S-35S. PubMed ID: 10507506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Applications and safety of modern antidepressants in patients with liver diseases].
    Dubarek W; Kucia K
    Wiad Lek; 2007; 60(1-2):28-33. PubMed ID: 17607965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.